Table 3.
Associations between GrimAge measurements at Y15–Y20 and incident T2D during Y15–Y25 by BMI status at Y15
Normal weight at Y15 (BMI <25 kg/m2, N = 345) | Overweight at Y15 (BMI 25–30 kg/m2, N = 394) | With obesity at Y15 (BMI ≥30 kg/m2, N = 318) | Pinteraction | |
---|---|---|---|---|
Model 1: diabetes vs. prediabetes and normal glucose | ||||
Chronological age | 1.28 (1.05–1.57)* | 1.06 (0.92–1.22) | 1.04 (0.95–1.14) | 0.29 |
GrimAge† | 1.09 (0.98–1.20) | 1.04 (0.98–1.10) | 1.06 (1.01–1.11)* | 0.19 |
GrimAA† | 1.02 (0.89–1.16) | 1.04 (0.97–1.10) | 1.08 (1.00–1.15)* | 0.30 |
Positive GrimAA | 2.12 (0.58–7.72) | 0.79 (0.44–1.43) | 2.57 (1.61–4.11)*** | 0.94 |
Positive 5yr GrimAA | 0.58 (0.17–1.94) | 0.42 (0.14–1.27) | 1.83 (1.17–2.85)*** | <0.01 |
Model 2: diabetes vs. normal glucose (prediabetes excluded) | ||||
Chronological age | 1.40 (1.11–1.76)** | 1.06 (0.91–1.24) | 1.14 (1.03–1.27)* | 0.29 |
GrimAge | 1.09 (0.98–1.20) | 1.03 (0.96–1.10) | 1.08 (1.03–1.14)** | 0.58 |
GrimAA | 1.00 (0.88–1.14) | 1.02 (0.95–1.11) | 1.05 (0.98–1.13) | 0.38 |
Positive GrimAA | 2.14 (0.56–8.24) | 0.63 (0.32–1.48) | 2.49 (1.44–4.31)** | 0.94 |
Positive 5yr GrimAA | 0.46 (0.13–1.56) | 0.38 (0.10–0.89)* | 2.35 (1.40–3.94)** | <0.01 |
Model 3: hyperglycemia (diabetes or prediabetes) vs. normal glucose | ||||
Chronological age | 1.15 (1.08–1.22)** | 1.06 (1.00–1.13) | 1.17 (1.09–1.26)*** | 0.09 |
GrimAge | 1.07 (1.02–1.11)** | 1.03 (0.99–1.06) | 1.06 (1.02–1.10)** | 0.72 |
GrimAA | 1.03 (0.98–1.08) | 1.03 (0.98–1.07) | 1.00 (0.95–1.05) | 0.29 |
Positive GrimAA | 2.15 (1.35–3.42)** | 0.94 (0.66–1.35) | 1.15 (0.80–1.67) | 0.04 |
Positive 5yr GrimAA | 1.20 (0.82–1.76) | 1.05 (0.77–1.43) | 1.90 (1.31–2.76)*** | 0.08 |
Data are OR (95% CI). Models are adjusted for race, sex, education, smoking status, physical activity, alcohol drinking, and field center.
For GrimAge and GrimAA, the ORs and 95% CIs were calculated based on 1-year increase of each measurement.
P < 0.05;
P < 0.01;
P < 0.001.